Pamidronate Disodium Injection
Product Images NDC 67457-430

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pamidronate Disodium (NDC 67457-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Image 01
Pamidronate Disodium Injection 30 mg/10 mL (3 mg/mL) single-use vial carton label. The label includes active ingredient and inactive components, storage instructions, dilution warnings, and manufacturer information. Manufactured for Mylan Institutional LLC, product NDC 67457-430-10, made in India. The label emphasizes that the medication is sterile and for intravenous infusion, with a warning not to mix with calcium-containing infusion solutions.*
FDA Label Image

Image 02

Image 02
Packaging label for Pamidronate Disodium Injection 90 mg/10 mL (9 mg/mL) by Mylan Institutional LLC. The label includes dosage form (injection), storage instructions, dilution warning, and notes that it is a single-use vial for intravenous infusion. The label also lists inactive ingredients and manufacturing information.*
FDA Label Image

Structure (Pamidronate Inj Mylan Figure 01)

Structure (Pamidronate Inj Mylan Figure 01)
Chemical structure of Pamidronate Disodium, illustrating the molecular arrangement with nitrogen, carbon, oxygen, hydrogen, phosphorus, and sodium atoms as part of the compound.*
FDA Label Image

Image (Pamidronate Inj Mylan Figure 02)

Image (Pamidronate Inj Mylan Figure 02)
A scatter plot chart titled "Pamidronate Renal CL vs CLcr" showing observed and predicted renal clearance (CL) of pamidronate disodium in mL/min plotted against creatinine clearance (CLcr) in mL/min. The chart includes observed data points, predicted values, and confidence interval lines (lower and upper 95% CI).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.